Literature DB >> 18523842

Alkaloids from the seeds of Peganum harmala showing antiplasmodial and vasorelaxant activities.

Adil Astulla1, Kazumasa Zaima, Yosuke Matsuno, Yusuke Hirasawa, Wiwied Ekasari, Aty Widyawaruyanti, Noor Cholies Zaini, Hiroshi Morita.   

Abstract

Bioassay-guided purification from the seeds of Peganum harmala led to the isolation of harmine (1), harmaline (2), vasicinone (3), and deoxyvasicinone (4). Harmine (1) and harmaline (2) showed a moderate in vitro antiplasmodial activity against Plasmodium falciparum. Quinazoline alkaloid, vasicinone (3), showed a vasorelaxant activity against phenylephrine-induced contraction of isolated rat aorta.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18523842     DOI: 10.1007/s11418-008-0259-7

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  20 in total

1.  In vitro antiplasmodial activity of 18 plants used in Congo Brazzaville traditional medicine.

Authors:  S F Mbatchi; B Mbatchi; J T Banzouzi; T Bansimba; G F Nsonde Ntandou; J-M Ouamba; A Berry; F Benoit-Vical
Journal:  J Ethnopharmacol       Date:  2005-10-27       Impact factor: 4.360

2.  Vasorelaxant activity of cyclic peptide, cyclosquamosin B, from Annona squamosa.

Authors:  Hiroshi Morita; Toru Iizuka; Chee-Yan Choo; Kit-Lam Chan; Koichi Takeya; Jun'ichi Kobayashi
Journal:  Bioorg Med Chem Lett       Date:  2006-06-19       Impact factor: 2.823

3.  Vasorelaxant effects of harmine and harmaline extracted from Peganum harmala L. seeds in isolated rat aorta.

Authors:  Hicham Berrougui; Carmen Martín-Cordero; Abdelouahed Khalil; Mohammed Hmamouchi; Abdelkader Ettaib; Elisa Marhuenda; María Dolores Herrera
Journal:  Pharmacol Res       Date:  2006-05-01       Impact factor: 7.658

4.  Inhibition of mitochondrial monoamine oxidase of the rat uterus and liver by clorglyine, pargyline and harmine.

Authors:  D S Grosso; A M Gawienowski
Journal:  Biochem Pharmacol       Date:  1976-04-15       Impact factor: 5.858

5.  The sensitivity of Plasmodium protein synthesis to prokaryotic ribosomal inhibitors.

Authors:  A S Budimulja; P Tapchaisri; P Wilairat; S Marzuki
Journal:  Mol Biochem Parasitol       Date:  1997-01       Impact factor: 1.759

6.  Peganum harmala: its use in certain dermatoses.

Authors:  M El-Saad El-Rifaie
Journal:  Int J Dermatol       Date:  1980-05       Impact factor: 2.736

7.  An in vitro evaluation of human DNA topoisomerase I inhibition by Peganum harmala L. seeds extract and its beta-carboline alkaloids.

Authors:  Armin Madadkar Sobhani; Sultan-Ahmad Ebrahimi; Massoud Mahmoudian
Journal:  J Pharm Pharm Sci       Date:  2002 Jan-Apr       Impact factor: 2.327

8.  Ethnobotanical survey and in vitro antiplasmodial activity of plants used in traditional medicine in Burkina Faso.

Authors:  S Sanon; E Ollivier; N Azas; V Mahiou; M Gasquet; C T Ouattara; I Nebie; A S Traore; F Esposito; G Balansard; P Timon-David; F Fumoux
Journal:  J Ethnopharmacol       Date:  2003-06       Impact factor: 4.360

Review 9.  beta-Carbolines, psychoactive compounds in the mammalian body. Part II: Effects.

Authors:  M M Airaksinen; I Kari
Journal:  Med Biol       Date:  1981-08

Review 10.  Banisterine and Parkinson's disease.

Authors:  J R Sanchez-Ramos
Journal:  Clin Neuropharmacol       Date:  1991-10       Impact factor: 1.592

View more
  21 in total

1.  Vasorelaxant effect of FR900359 from Ardisia crenata on rat aortic artery.

Authors:  Kazumasa Zaima; Jun Deguchi; Yosuke Matsuno; Toshio Kaneda; Yusuke Hirasawa; Hiroshi Morita
Journal:  J Nat Med       Date:  2012-03-03       Impact factor: 2.343

2.  In vitro ovicidal activity of Peganum harmala seeds extract on the eggs of Fasciola hepatica.

Authors:  Mohammad Moazeni; Zahra Sadat Saadaty Ardakani; Mohammad Jamal Saharkhiz; Jafar Jalaei; Ali Asghar Khademolhoseini; Shahab Shams Esfand Abad; Amir Mootabi Alavi
Journal:  J Parasit Dis       Date:  2016-08-29

3.  Antiplasmodial potential of medicinal plant extracts from Malaiyur and Javadhu hills of South India.

Authors:  Chinnaperumal Kamaraj; Naveen Kumar Kaushik; Dinesh Mohanakrishnan; Gandhi Elango; Asokan Bagavan; Abdul Abduz Zahir; Abdul Abdul Rahuman; Dinkar Sahal
Journal:  Parasitol Res       Date:  2011-06-04       Impact factor: 2.289

4.  Vasorelaxant activity of indole alkaloids from Tabernaemontana dichotoma.

Authors:  Kazumasa Zaima; Ikumi Koga; Nobuhide Iwasawa; Takahiro Hosoya; Yusuke Hirasawa; Toshio Kaneda; Intan Safinar Ismail; Nordin Hj Lajis; Hiroshi Morita
Journal:  J Nat Med       Date:  2012-02-21       Impact factor: 2.343

Review 5.  Antibacterial, Antifungal, Antiviral, and Antiparasitic Activities of Peganum harmala and Its Ingredients: A Review.

Authors:  Zihao Zhu; Shujuan Zhao; Changhong Wang
Journal:  Molecules       Date:  2022-06-29       Impact factor: 4.927

6.  An alternative paradigm for the role of antimalarial plants in Africa.

Authors:  Steven Maranz
Journal:  ScientificWorldJournal       Date:  2012-04-19

7.  Biotransformation of perfumery terpenoids, (-)-ambrox® by a fungal culture Macrophomina phaseolina and a plant cell suspension culture of Peganum harmala.

Authors:  Syed Ghulam Musharraf; Sheeba Naz; Asma Najeeb; Saifullah Khan; M Iqbal Choudhary
Journal:  Chem Cent J       Date:  2012-08-05       Impact factor: 4.215

8.  Novel mechanism of harmaline on inducing G2/M cell cycle arrest and apoptosis by up-regulating Fas/FasL in SGC-7901 cells.

Authors:  Yihai Wang; Chunhua Wang; Chenguang Jiang; Hong Zeng; Xiangjiu He
Journal:  Sci Rep       Date:  2015-12-18       Impact factor: 4.379

9.  The β-carboline alkaloid harmine inhibits telomerase activity of MCF-7 cells by down-regulating hTERT mRNA expression accompanied by an accelerated senescent phenotype.

Authors:  Lei Zhao; Michael Wink
Journal:  PeerJ       Date:  2013-10-01       Impact factor: 2.984

Review 10.  Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids.

Authors:  Milad Moloudizargari; Peyman Mikaili; Shahin Aghajanshakeri; Mohammad Hossein Asghari; Jalal Shayegh
Journal:  Pharmacogn Rev       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.